References
- Bharali DJ, Khalil M, Gurbuz M, et al. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomedicine 2009;4:1–7
- Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 2011;63:131–5
- Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387–92
- Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001;74:47–61
- Senior J, Delgado C, Fisher D, et al. Influence of surface hydrophilicity of liposomes on their interaction with plasma-protein and clearance from the circulation – studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1991;1062:77–82
- Torchilin VP, Omelyanenko VG, Papisov MI, et al. Poly(ethylene glycol) on the liposome surface – on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta Biomembr 1994;1195:11–20
- Hatakeyama H, Akita H, Harashima H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv Drug Deliv Rev 2011;63:152–60
- Du H, Chandaroy P, Hui SW. Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. Biochim Biophysica Acta 1997;1326:236–48
- Amoozgar Z, Park JY, Lin QN, Yeo Y. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Mol Pharm 2012;9:1262–70
- Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996;56:1194–8
- Parveen S, Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol 2011;670:372–83
- Ishak RAH, Awad GAS, Zaki NM, et al. A comparative study of chitosan shielding effect on nano-carriers hydrophilicity and biodistribution. Carbohyd Polym 2013;94:669–76
- Lee H, Dellatore SM, Miller WM, Messersmith PB. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007;318:426–30
- Ryu J, Ku SH, Lee M, Park CB. Bone-like peptide/hydroxyapatite nanocomposites assembled with multi-level hierarchical structures. Soft Matter 2011;7:7201–6
- Wang GF, Huang H, Zhang XJ, Wang L. Electrically contacted enzyme based on dual hairpin DNA structure and its application for amplified detection of Hg2+. Biosens Bioelectron 2012;35:108–14
- Lin MH, Liu YJ, Chen XF, et al. Poly(dopamine) coated gold nanocluster functionalized electrochemical immunosensor for brominated flame retardants using multienzyme-labeling carbon hollow nanochains as signal amplifiers. Biosens Bioelectron 2013;45:82–8
- Black KCL, Yi J, Rivera JG, et al. Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy. Nanomedicine (UK) 2013;8:17–28
- Park J, Brust TF, Lee HJ, et al. Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers. ACS Nano 2014;8:3347–5
- Gullotti E, Park J, Yeo Y. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles. Pharm Res 2013;30:1956–67
- Du X, Li LX, Li JS, et al. UV-triggered dopamine polymerization: control of polymerization, surface coating, and photopatterning. Adv Mater 2014;26:8029–33
- Wei Q, Zhang FL, Li J, et al. Oxidant-induced dopamine polymerization for multifunctional coatings. Polym Chem 2010;1:1430–3
- Liu Y, Ai K, Liu J, et al. Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy. Adv Mater 2013;25:1353–9
- Leane MM, Nankervis R, Smith A, Illum L. Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms. Int J Pharm 2004;271:241–9
- Errington N, Harding SE, Varum KM, Illum L. Hydrodynamic characterization of chitosans varying in degree of acetylation. Int J Biol Macromol 1993;15:113–17
- Docter D, Distler U, Storck W, et al. Quantitative profiling of the protein coronas that form around nanoparticles. Nat Protoc 2014;9:2030–44
- Monopoli MP, Walczyk D, Campbell A, et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011;133:2525–34
- Casals E, Pfaller T, Duschl A, et al. Time evolution of the nanoparticle protein Corona. ACS Nano 2010;4:3623–32
- Martel J, Wu CY, Young JD. Critical evaluation of gamma-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles. PLoS One 2010;5:e10343
- Young JD, Martel J, Young L, et al. Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One 2009;4:e4417
- Ehrenberg MS, Friedman AE, Finkelstein JN, et al. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 2009;30:603–10
- Wu C-Y, Young L, Young D, et al. Bions: a family of biomimetic mineralo-organic complexes derived from biological fluids. PLoS One 2013;8:e75501
- Tabata Y, Ikada Y. Effect of the size and surface-charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988;9:356–62
- Cheng ZL, Al Zaki A, Hui JZ, et al. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 2012;338:903–10
- Goldberg MS, Hook SS, Wang AZ, et al. Biotargeted nanomedicines for cancer: six tenets before you begin. Nanomedicine (UK) 2013;8:299–308
- Abouelmagd SA, Sun B, Chang AC, et al. Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right? Mol Pharm 2015;12:997–1003
- Mittal G, Sahana DK, Bhardwaj V, Kumar MNVR. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release 2007;119:77–85
- Milani S, Bombelli FB, Pitek AS, et al. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano 2012;6:2532–41
- Walkey CD, Olsen JB, Guo H, et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 2012;134:2139–47
- Salvati A, Pitek AS, Monopoli MP, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 2013;8:137–43
- Sherwood L. Human physiology: from cells to systems. 8th ed. Belmont: Cengage Learning; 2011
- Tahara K, Sakai T, Yamamoto H, et al. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 2009;382:198–204
- Yue ZG, Wei W, Lv PP, et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 2011;12:2440–6